{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:06:43Z","timestamp":1774462003520,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41386-018-0306-3","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T10:55:49Z","timestamp":1546858549000},"page":"1141-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Insulin modulates the strong reinforcing effects of nicotine and changes in insulin biomarkers in a rodent model of diabetes"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7418-1524","authenticated-orcid":false,"given":"Bryan","family":"Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo J.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P.","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelina J.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8121-8463","authenticated-orcid":false,"given":"Charles T.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Serafine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arbi","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"O\u2019Dell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"306_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1479164109346359","volume":"64","author":"FK Bishop","year":"2009","unstructured":"Bishop FK, Maahs DM, Snell-Bergeon JK, Ogden LG, Kinney GL, Rewers M. Lifestyle risk factors for atherosclerosis in adults with type 1 diabetes. Diab Vasc Dis Res. 2009;64:269\u201375.","journal-title":"Diab Vasc Dis Res"},{"key":"306_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1464-5491.2005.01471.x","volume":"22","author":"GV Gill","year":"2005","unstructured":"Gill GV, Morgan C, MacFarlane IA. Awareness and use of smoking cessation treatments among diabetic patients. Diabet Med. 2005;22:658\u201360.","journal-title":"Diabet Med"},{"key":"306_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/nur.4770170406","volume":"17","author":"D Haire-Joshu","year":"1994","unstructured":"Haire-Joshu D, Heady S, Thomas L, Schechtman K, Fisher EB. Depressive symptomatology and smoking among persons with diabetes. Res Nurs Health. 1994;17:273\u201382.","journal-title":"Res Nurs Health"},{"key":"306_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0306-4603(00)00077-0","volume":"26","author":"JG Spangler","year":"2006","unstructured":"Spangler JG, Summerso JH, Bell RA, Konen JC. Smoking status and psychosocial variables in type 1 diabetes mellitus. Addict Behav. 2006;26:21\u20139.","journal-title":"Addict Behav"},{"key":"306_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1262-3636(07)70301-4","volume":"32","author":"O Scemama","year":"2006","unstructured":"Scemama O, Hamo-Tchatchouang E, Le Faou AL, Altman JJ. Difficulties of smoking cessation in diabetic inpatients benefiting from a systematic consultation to help them to give up smoking. Diabetes Metab. 2006;32:435\u201341.","journal-title":"Diabetes Metab"},{"key":"306_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.04.013","volume":"85","author":"S Tonstad","year":"2009","unstructured":"Tonstad S. Cigarette smoking, smoking cessation, and diabetes. Diabetes Res Clin Pract. 2009;85:4\u201313.","journal-title":"Diabetes Res Clin Pract"},{"key":"306_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00213-017-4592-y","volume":"234","author":"JA Pipkin","year":"2017","unstructured":"Pipkin JA, Cruz B, Flores RJ, Hinojosa CA, Carcoba LM, Ibarra M, et al. Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes. Psychopharmacology. 2017;234:1615\u201322.","journal-title":"Psychopharmacology"},{"key":"306_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/adb.12074","volume":"19","author":"LE O\u2019Dell","year":"2014","unstructured":"O\u2019Dell LE, Natividad LA, Pipkin JA, Roman F, Torres I, Jurado J, et al. Enhanced nicotine self-administration and suppressed dopaminergic systems in a rat model of diabetes. Addict Biol. 2014;19:1006\u201319.","journal-title":"Addict Biol"},{"key":"306_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","volume":"51","author":"S Lenzen","year":"2008","unstructured":"Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51:216\u201326.","journal-title":"Diabetologia"},{"key":"306_CR10","doi-asserted-by":"publisher","first-page":"11469","DOI":"10.1523\/JNEUROSCI.2338-16.2016","volume":"36","author":"CR Ferrario","year":"2016","unstructured":"Ferrario CR, Labou\u00e8be G, Liu S, Nieh EH, Routh VH, Xu S, et al. Homeostasis meets motivation in the battle to control food intake. J Neurosci. 2016;36:11469\u201381.","journal-title":"J Neurosci"},{"key":"306_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.yfrne.2009.10.004","volume":"31","author":"NS Narayanan","year":"2010","unstructured":"Narayanan NS, Guarnieri DJ, DiLeone RJ. Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol. 2010;31:104.","journal-title":"Front Neuroendocrinol"},{"key":"306_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0006-8993(02)04087-8","volume":"964","author":"DP Figlewicz","year":"2003","unstructured":"Figlewicz DP, Evans SB, Murphy J, Hoen M, Baskin DG. Expression of receptors for insulin and leptin in the ventral tegmental area\/substantia nigra (VTA\/SN) of the rat. Brain Res. 2003;964:107\u201315.","journal-title":"Brain Res"},{"key":"306_CR13","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1152\/ajpendo.00087.2015","volume":"308","author":"EG Mietlicki-Baase","year":"2015","unstructured":"Mietlicki-Baase EG, Olivos DR, Jeffrey BA, Hayes MR. Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake. Am J Physiol Endocrinol Metab. 2015;308:1116\u201322.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"306_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1749-6632.2000.tb06682.x","volume":"909","author":"GF Koob","year":"2000","unstructured":"Koob GF. Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci. 2000;909:170\u201385.","journal-title":"Ann N Y Acad Sci"},{"key":"306_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","volume":"164","author":"GF Koob","year":"2007","unstructured":"Koob GF, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007;164:1149\u201359.","journal-title":"Am J Psychiatry"},{"key":"306_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejphar.2003.08.099","volume":"480","author":"HD Mansvelder","year":"2003","unstructured":"Mansvelder HD, De Rover M, McGehee DS, Brussaard AB. Cholinergic modulation of dopaminergic reward areas: upstream and downstream target of nicotine addiction. Eur J Pharmacol. 2003;480:117\u201323.","journal-title":"Eur J Pharmacol"},{"key":"306_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/272827a0","volume":"272","author":"J Havrankova","year":"1978","unstructured":"Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 1978;272:388\u201394.","journal-title":"Nature"},{"key":"306_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0301-0082(91)90015-S","volume":"36","author":"JW Unger","year":"1991","unstructured":"Unger JW, Livingston JN, Moss AM. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol. 1991;36:343\u201362.","journal-title":"Prog Neurobiol"},{"key":"306_CR19","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1038\/ncomms9543","volume":"6","author":"MA Stouffer","year":"2015","unstructured":"Stouffer MA, Woods CA, Patel JC, Lee CR, Witkovsky P, Bao L, et al. Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward. Nat Commun. 2015;6:8543.","journal-title":"Nat Commun"},{"key":"306_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.pnpbp.2015.06.005","volume":"65","author":"LE O\u2019Dell","year":"2016","unstructured":"O\u2019Dell LE, Nazarian A. Enhanced vulnerability to tobacco use in persons with diabetes: a behavioral and neurobiological framework. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;65:288\u201396.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"306_CR21","first-page":"31855","volume":"17","author":"J \u00cdbias","year":"2018","unstructured":"\u00cdbias J, O\u2019Dell LE, Nazarian A. Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes. Behav Brain Res. 2018;17:31855\u201367.","journal-title":"Behav Brain Res"},{"key":"306_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.physbeh.2011.09.003","volume":"105","author":"N Ho","year":"2012","unstructured":"Ho N, Balu DT, Hilario MRF, Blendy JA, Lucki I. Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol Behav. 2012;105:702\u20138.","journal-title":"Physiol Behav"},{"key":"306_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbr.2016.04.004","volume":"307","author":"RJ Flores","year":"2006","unstructured":"Flores RJ, Pipkin JA, Uribe KP, Perez A, O\u2019Dell LE. Estradiol promotes the rewarding effects of nicotine in female rats. Behav Brain Res. 2006;307:258\u201363.","journal-title":"Behav Brain Res"},{"key":"306_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbr.2013.10.003","volume":"257","author":"LA Natividad","year":"2013","unstructured":"Natividad LA, Torres OV, Friedman TC, O\u2019Dell LE. Adolescence is a period of development characterized by short- and long-term vulnerability to the rewarding effects of nicotine and reduces sensitivity to the anorectic effect of this drug. Behav Brain Res. 2013;257:275\u201385.","journal-title":"Behav Brain Res"},{"key":"306_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.pbb.2007.01.004","volume":"86","author":"LE O\u2019Dell","year":"2007","unstructured":"O\u2019Dell LE, Koob GF. \u2018Nicotine deprivation effect\u2019 in rats with intermittent 23-hour access to intravenous self-administration. Pharmacol Biochem Behav. 2007;86:346\u201353.","journal-title":"Pharmacol Biochem Behav"},{"key":"306_CR26","first-page":"30406","volume":"9384","author":"J Ramos","year":"2017","unstructured":"Ramos J, Hernandez-Casner C, Cruz B, Serafine KM. Sex differences in high fat diet-induced impairments to striatal Akt signaling and enhanced sensitivity to the behavioral effects of dopamine D2\/D3 receptor agonist quinpirole. Physiol Behav. 2017;9384:30406\u20137.","journal-title":"Physiol Behav"},{"key":"306_CR27","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1124\/jpet.106.115600","volume":"320","author":"RJ Sevak","year":"2007","unstructured":"Sevak RJ, Koek W, Galli A, France CP. Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats. J Pharmacol Exp Ther. 2007;320:1216\u201323.","journal-title":"J Pharmacol Exp Ther"},{"key":"306_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.drugalcdep.2014.03.028","volume":"140","author":"JR Richardson","year":"2014","unstructured":"Richardson JR, Pipkin JA, O\u2019Dell LE, Nazarian A. Insulin resistant rats display enhanced rewarding effects of nicotine. Drug Alcohol Depend. 2014;140:205\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"306_CR29","first-page":"1482","volume":"274","author":"PJ Havel","year":"1998","unstructured":"Havel PJ, Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen CL, et al. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol. 1998;274:1482\u201391.","journal-title":"Am J Physiol"},{"key":"306_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pbb.2010.03.002","volume":"97","author":"DP Figlewicz","year":"2010","unstructured":"Figlewicz DP, Sipols AJ. Energy regulatory signals and food reward. Pharmacol Biochem Behav. 2010;97:15\u201324.","journal-title":"Pharmacol Biochem Behav"},{"key":"306_CR31","first-page":"1","volume":"37","author":"E Stice","year":"2012","unstructured":"Stice E, Figlewicz DP, Gosnell BA, Levine AS, Pratt WE. The contribution of brain reward circuits to the obesity epidemic. Neurosci Biobehav Rev. 2012;37:1\u201312.","journal-title":"Neurosci Biobehav Rev"},{"key":"306_CR32","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","volume":"69","author":"TA Lutz","year":"2012","unstructured":"Lutz TA. Control of energy homeostasis by amylin. Cell Mol Life Sci. 2012;69:1947\u201365.","journal-title":"Cell Mol Life Sci"},{"key":"306_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.metabol.2013.09.010","volume":"63","author":"YS Lee","year":"2014","unstructured":"Lee YS, Jun HS. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells. Metabolism. 2014;63:9\u201319.","journal-title":"Metabolism"},{"key":"306_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11695-018-3312-y","volume":"28","author":"B Keleidari","year":"2018","unstructured":"Keleidari B, Mofrad RM, Shahmiri SS, Sanei MH, Kolahdouzan M, Sheikhbahaei E. The impacts of gastroileostomy rat model on glucagon-like peptide-1: a promising model to control type 2 diabetes mellitus. Obes Surg. 2018;28:1\u20137.","journal-title":"Obes Surg"},{"key":"306_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13300-011-0002-3","volume":"2","author":"C Koliaki","year":"2011","unstructured":"Koliaki C, Doupis J. Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus. Diabetes Ther. 2011;2:101\u201321.","journal-title":"Diabetes Ther"},{"key":"306_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0006-8993(02)02887-1","volume":"946","author":"Z Li","year":"2002","unstructured":"Li Z, Zhang W, Grunberger G, Sima AAF. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. 2002;946:212\u201331.","journal-title":"Brain Res"},{"key":"306_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/hipo.20636","volume":"10","author":"RJ Gomes","year":"2009","unstructured":"Gomes RJ, de Oliveira CA, Ribeiro C, Mota CS, Moura LP, Tognoli LM, et al. Effects of exercise training on hippocampus concentrations of insulin and IGF-1 in diabetic rats. Hippocampus. 2009;10:981\u20137.","journal-title":"Hippocampus"},{"key":"306_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cmet.2005.11.013","volume":"3","author":"RW Gelling","year":"2006","unstructured":"Gelling RW, Morton GJ, Morrison CD, Niswender KD, Myers MG Jr, Rhodes CJ, et al. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab. 2006;3:67\u201373.","journal-title":"Cell Metab"},{"key":"306_CR39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0006-8993(00)02573-7","volume":"874","author":"BE Levin","year":"2000","unstructured":"Levin BE. Glucose-regulated dopamine release from substantia nigra neurons. Brain Res. 2000;874:158\u201364.","journal-title":"Brain Res"},{"key":"306_CR40","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1523\/JNEUROSCI.5749-09.2010","volume":"30","author":"X Ren","year":"2010","unstructured":"Ren X, Ferreira JG, Zhou L, Shammah-Lagnado SJ, Yeckel CW, de Araujo IE. Nutrient selection in the absence of taste receptor signaling. J Neurosci. 2010;30:8012\u201323.","journal-title":"J Neurosci"},{"key":"306_CR41","doi-asserted-by":"publisher","first-page":"e77284","DOI":"10.1371\/journal.pone.0077284","volume":"8","author":"E Egecioglu","year":"2013","unstructured":"Egecioglu E, Engel JA, Jerlhag E. The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice. PLoS One. 2013;8:e77284.","journal-title":"PLoS One"},{"key":"306_CR42","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nn.4540","volume":"20","author":"LM Tuesta","year":"2017","unstructured":"Tuesta LM, Chen Z, Duncan A, Fowler CD, Ishikawa M, Lee BR, et al. GLP-1 acts on habenular avoidance to control nicotine intake. Nat Neurosci. 2017;20:708\u201316.","journal-title":"Nat Neurosci"},{"issue":"sup1","key":"306_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2000.10736099","volume":"32","author":"Kenneth Blum","year":"2000","unstructured":"Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs. 2000;32:1\u2013112.","journal-title":"Journal of Psychoactive Drugs"},{"key":"306_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4682-5-24","volume":"5","author":"K Blum","year":"2008","unstructured":"Blum K, Chen AL, Chen TJ, Braverman ER, Reinking J, Blum SH, et al. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long-term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model. 2008;5:24.","journal-title":"Theor Biol Med Model"},{"key":"306_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/npp.2009.185","volume":"35","author":"NA Fineberg","year":"2010","unstructured":"Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, et al. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology. 2010;35:591\u2013604.","journal-title":"Neuropsychopharmacology"},{"key":"306_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000068650","volume":"77","author":"R Galici","year":"2003","unstructured":"Galici R, Galli A, Jones DJ, Sanchez TA, Saunders C, Frazer A, et al. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology. 2003;77:132\u201340.","journal-title":"Neuroendocrinology"},{"key":"306_CR47","first-page":"299","volume":"75","author":"J Kamei","year":"1997","unstructured":"Kamei J, Ohsawa M. Effects of streptozotocin-induced diabetes on place conditioning action of cocaine in mice. J Pharmacol. 1997;75:299\u2013301.","journal-title":"J Pharmacol"},{"key":"306_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2007.11.047","volume":"581","author":"RJ Sevak","year":"2008","unstructured":"Sevak RJ, Owens WA, Koek W, Galli A, Daws LC, France CP. Behavioral effects of amphetamine in streptozotocin-treated rats. Eur J Pharmacol. 2008;581:105\u201312.","journal-title":"Eur J Pharmacol"},{"key":"306_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pbb.2014.11.008","volume":"128","author":"AH Bayat","year":"2015","unstructured":"Bayat AH, Haghparast A. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats. Pharmacol Biochem Behav. 2015;128:8\u201313.","journal-title":"Pharmacol Biochem Behav"},{"key":"306_CR50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0014-2999(96)00804-7","volume":"318","author":"J Kamei","year":"1996","unstructured":"Kamei J, Ohsawa M. Effects of diabetes on methamphetamine-induced place preference in mice. Eur J Pharmacol. 1996;318:251\u20136.","journal-title":"Eur J Pharmacol"},{"key":"306_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0014-2999(97)01302-2","volume":"337","author":"J Kamei","year":"1997","unstructured":"Kamei J, Ohsawa M, Suzuki T, Nagase H. Modification of morphine-induced place preference by diabetes. Eur J Pharmacol. 1997;337:137\u201345.","journal-title":"Eur J Pharmacol"},{"key":"306_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2013.03.024","volume":"543","author":"R Samandari","year":"2013","unstructured":"Samandari R, Chizari A, Hassanpour R, Mousavi Z, Haghparast A. Streptozotocin-induced diabetes affects the development and maintenance of morphine reward in rats. Neurosci Lett. 2013;543:90\u20134.","journal-title":"Neurosci Lett"},{"issue":"1-2","key":"306_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2005.05.043","volume":"517","author":"Rajkumar J. Sevak","year":"2005","unstructured":"Sevak RJ, Koek W, France CP. Streptozotocin-induced diabetes differentially modifies haloperidol- and \u03b3-hydroxybutyric acid (GHB)-induced catalepsy. Eur J Pharmacol. 2005;517:64\u20137.","journal-title":"European Journal of Pharmacology"},{"key":"306_CR54","doi-asserted-by":"publisher","unstructured":"Morrow TJ. Animal models of painful diabetic neuropathy: the STZ rat model. Curr Protoc Neurosci. 2004. \n                    https:\/\/doi.org\/10.1002\/0471142301.ns0918s29\n                    \n                  .","DOI":"10.1002\/0471142301.ns0918s29"},{"key":"306_CR55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1046\/j.1444-2892.2003.00160.x","volume":"12","author":"M Wei","year":"2003","unstructured":"Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ. 2003;12:44\u201350.","journal-title":"Heart Lung Circ"},{"key":"306_CR56","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/(SICI)1096-9136(199711)14:11<919::AID-DIA456>3.0.CO;2-A","volume":"14","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med. 1997;14:919\u201328.","journal-title":"Diabet Med"},{"key":"306_CR57","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/BF03345405","volume":"34","author":"F Febo","year":"2011","unstructured":"Febo F, Molinari C, Piatti PM. Hypoglycemia and insulin treatment. J Endocrinol Invest. 2011;34:698\u2013701.","journal-title":"J Endocrinol Invest"},{"key":"306_CR58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1590\/S0001-37652013005000011","volume":"85","author":"LH Guerreiro","year":"2013","unstructured":"Guerreiro LH, Da Silva D, Sola-Penna M, Mizurini DM, Lima LM. Amylin induces hypoglycemia in mice. Acad Bras Cienc. 2013;85:349\u201354.","journal-title":"Acad Bras Cienc"},{"key":"306_CR59","doi-asserted-by":"publisher","first-page":"pyv014","DOI":"10.1093\/ijnp\/pyv014","volume":"18","author":"F Caravaggio","year":"2015","unstructured":"Caravaggio F, Borlido C, Hahn M, Feng Z, Fervaha G, Gerretsen P, et al. Reduced insulin sensitivity is related to less endogenous dopamine at D2\/3 receptors in the ventral striatum of healthy nonobese humans. Int J Neuropsychopharmacol. 2015;18:pyv014.","journal-title":"Int J Neuropsychopharmacol"},{"key":"306_CR60","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1471-4159.1983.tb13590.x","volume":"40","author":"ME Trulson","year":"1983","unstructured":"Trulson ME, Himmel CD. Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats. J Neurochem. 1983;40:1456\u20139.","journal-title":"J Neurochem"},{"key":"306_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1471-4159.1990.tb13294.x","volume":"54","author":"Z Lackovic","year":"1990","unstructured":"Lackovic Z, Salkovic M, Kuci Z, Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J Neurochem. 1990;54:143\u20137.","journal-title":"J Neurochem"},{"key":"306_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0006-8993(94)90269-0","volume":"634","author":"T Kono","year":"1994","unstructured":"Kono T, Takada M. Dopamine depletion in nigrostriatal neurons in the genetically diabetic rat. Brain Res. 1994;634:155\u20138.","journal-title":"Brain Res"},{"key":"306_CR63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2337\/diab.32.3.222","volume":"32","author":"EA Crandall","year":"1983","unstructured":"Crandall EA, Fernstrom JD. Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain. Diabetes. 1983;32:222\u201330.","journal-title":"Diabetes"},{"key":"306_CR64","first-page":"432","volume":"236","author":"M Bitar","year":"1986","unstructured":"Bitar M, Koulu M, Rapoport SI, Linnoila M. Diabetes-induced alteration in brain monoamine metabolism in rats. J Pharmacol Exp Ther. 1986;236:432\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"306_CR65","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/36116","volume":"391","author":"DJ Withers","year":"1998","unstructured":"Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 1998;391:900\u20134.","journal-title":"Nature"},{"key":"306_CR66","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1073\/pnas.1707047115","volume":"115","author":"JK Brynildsen","year":"2018","unstructured":"Brynildsen JK, Lee BG, Perron IJ, Jin S, Kim SF, Blendy JA. Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal. Proc Natl Acad Sci USA. 2018;115:4282\u20137.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0306-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:05:01Z","timestamp":1684616701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-018-0306-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["306"],"URL":"https:\/\/doi.org\/10.1038\/s41386-018-0306-3","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"13 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}